2023
DOI: 10.1002/mds.29334
|View full text |Cite
|
Sign up to set email alerts
|

Christmas‐Related Reduction in Beta Activity in Parkinson's Disease

Abstract: Background Subthalamic nucleus (STN) beta (13 ‐ 35 Hz) activity is a biomarker reflecting motor state in Parkinson's disease (PD). Adaptive deep brain stimulation (DBS) aims to use beta activity for therapeutic adjustments, but many aspects of beta activity in real‐life situations are unknown. Objective The aim was to investigate Christmas‐related influences on beta activity in PD. Methods Differences in Christmas Day to nonfestive daily averages in chronic biomarker recordings in 4 PD patients with a sensing‐… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 32 publications
0
5
0
Order By: Relevance
“…By not measuring the state of the brain before stimulation, we might not have captured the full impact of tDCS effects. This limitation should be considered when interpreting our results and could be addressed in future research by (99)(100)(101). Consequently, the variability in our results could be a side-effect of circadian rhythm fluctuations.…”
Section: Discussionmentioning
confidence: 92%
“…By not measuring the state of the brain before stimulation, we might not have captured the full impact of tDCS effects. This limitation should be considered when interpreting our results and could be addressed in future research by (99)(100)(101). Consequently, the variability in our results could be a side-effect of circadian rhythm fluctuations.…”
Section: Discussionmentioning
confidence: 92%
“…To collect several specific symptom and functionality domains multiple times daily, ecological momentary assessments (EMA) are introduced and proven to be feasible Challenges of chronic monitoring and concept for patient engagement in studies on naturalistic neuroscience in PD patients: single example for illustration of challenges in chronic biomarker acquisition in a 56-year old male PD patient with subthalamic DBS and peak biomarker recording at 22 Hz (right hemisphere). Data acquisition and analysis was performed as previously described [van Rheede et al, 2022;Feldmann et al, 2023, approved by the local ethics committee (EA2/256/60)] in parallel with clinical records at a post-operative rehabilitation. At a low-resolution of 3-days means, beta band suppression from the beginning toward the end of the stay reveals that clinical improvement through therapy optimization is also reflected in biomarker levels (start of rehab: 758.9 ± 400.7, end of rehab 273.96 ± 160.3, mean ± standard deviation), (A, top).…”
Section: Current Literaturementioning
confidence: 99%
“…21,67 Here, a particular focus should be put on long-term monitoring of brain signals outside of the clinic. 68,69 Further refinement of biomarker characterization outside the clinic should use objective symptom tracking, ecological momentary assessments, medication-intake logging, and "snapshot" tools to collect spectral characteristics of defined clinical states. 1 Ultimately, open access biomarker libraries should be established in which symptomspecific feedback signals are collected and validated to facilitate informed aDBS programming.…”
Section: Toward Electrophysiological Brain Biomarker Librariesmentioning
confidence: 99%
“…1). 21,67 Here, a particular focus should be put on long‐term monitoring of brain signals outside of the clinic 68,69 . Further refinement of biomarker characterization outside the clinic should use objective symptom tracking, ecological momentary assessments, medication‐intake logging, and “snapshot” tools to collect spectral characteristics of defined clinical states 1 .…”
Section: Toward Electrophysiological Brain Biomarker Librariesmentioning
confidence: 99%